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ABSTRACT
Secondary Parkinson’s disease or subacute Parkinson’s may occur after stroke, drug overdose carbon monoxide or manganese toxicity, and 
rarely owing to a brain tumor. Loss of dopaminergic neurons in the substansia negra pars compacta (SNc), or presence of the proteinaceous 
inclusions called Lewy bodies are thought to be the cause of Parkinson’s disease. Notwithstanding, in the past few decades, many case reports 
have been published describing Parkinson’s symptoms following either stroke, ischemia, toxicity, brain haemorrhage or rarely neoplasm.
LEARNING POINTS
• Brain tumours can cause secondary parkinsonism.
• This type of secondary parkinsonism improves when the tumour is removed. 
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INTRODUCTION
Hitherto, only a handful of studies of case series have described the development of new onset Parkinson’s disease (PD) caused by a focal 
brain lesion, and report that the site of the lesion has no relationship with the nigrostriatal pathway[1–3]. In addition, the few case reports that 
have been published in peer-reviewed journals have shown that the location of the brain lesion varies[4]. 
Iatrogenic or drug-induced symptoms usually emerge as subacute PD, may cause significant disability (especially in older adults), and are 
difficult to treat. Iatrogenic subacute PD can take weeks or even months to resolve completely[5,6].
Joutsa et al. found that stroke and neoplasia in the medial frontal lobe, thalamus and midbrain tegmentum are by far the most common causes 
of subacute PD. Only 38% of such patients had unilateral Parkinson’s symptoms, and over 85% had received anti-Parkinson’s medication[3]. 
We present an interesting case of a large anterior cranial fossa meningioma with mass effect on the caudate presenting with secondary 
parkinsonism. There was mechanical compression of the basal ganglia without direct basal ganglia involvement. 
CASE REPORT
A 65-year-old right-handed African American woman with no significant medical history presented with a 3-month history of progressive 
resting tremor of the right hand. The patient reported no headache or visual disturbance. On examination, she showed mild features of early 
PD, including bradykinesia and slight cogwheel rigidity at the elbows. Given the history of subacute onset of symptoms with progressive 
worsening, magnetic resonance imaging (MRI) of the brain with and without contrast was ordered. The MRI showed a mass measuring 
5.7×4.2×5.6 cm in the anterior cranial fossa. This mass had a moderate mass effect with oedema which was greater in the right than in the 
left lobe. The frontal horns were somewhat distorted and posteriorly displaced. 
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Figure 1. T2 FLAIR axial images show a large anterior cranial fossa 
mass (bifrontal) with surrounding vasogenic edema with a mass effect 
upon the overlying medial frontal lobes bilaterally with downward 
compression and mass effect on the caudate (A, B). A large, avidly 
enhancing midline anterior cranial fossa mass with a maximum size of 
5.7×4.2×5.6 cm is seen on axial and coronal sections (C, D)
The mass extended into the anterior margin of the suprasellar cistern and was abutting the anterior margin of the optic chiasm. The mass 
was a dural-based lesion and avidly enhancing, which was consistent with a meningioma (Fig. 1). 
The patient underwent tumor resection within 2 weeks. Following surgery, she noticed a gradual and continuous improvement in her tremor. 
The cogwheel rigidity improved after resection, but she continued to have stable mild right-hand resting tremor without further progression 
of the disease. Anti-Parkinson’s medication (carbidopa-levodopa) for mild residual parkinsonian features was discussed with the patient, but 
she chose to be observed only as symptoms did not affect her quality of life.
DISCUSSION 
Intracranial mass lesions can cause parkinsonism and resting tremor. This is an uncommon cause of parkinsonism and should be considered 
in the differential diagnosis in patients with an acute or subacute presentation of symptoms[7]. Removal of the mass can improve the 
parkinsonian symptoms, although chronic compression of the basal ganglia from tumor mass effects may cause residual parkinsonian 
features[7]. 
Acute or subacute movement disorders may prompt patients to seek urgent medical attention, but movement disorders caused by a 
basal ganglia lesion usually progress only slowly[1–4]. Parkinson’s symptoms can be caused by tumors in different brain locations outside 
the nigrostriatal pathway, including the midbrain, thalamus, and cingulate cortex, as reported in some case reports[8-14]. Response to anti-
Parkinson’s medications is often good, although complete remission may take weeks or months[8-14]. A thorough history should focus on 
medications, while a physical examination will help the correct diagnosis to be made promptly[5,-8]. An accurate diagnosis is essential for 
successful management[4, 13]. Symptoms in patients with slowly growing or benign brain tumors may mimic those of idiopathic Parkinson’s 
disease and can be misdiagnosed. However, an early diagnosis can be reached in these patients by obtaining neuroimaging studies such as 
computed tomography or MRI of the brain, thus reducing progression and facilitating early intervention[7].
CONCLUSION 
We present an interesting case of a large anterior cranial fossa meningioma with mass effect on the caudate and presenting with secondary 
parkinsonism. Mechanical compression of the basal ganglia without direct basal ganglia involvement caused the patient to develop residual 
right-hand resting tremor despite surgical resection, which suggests chronic damage to the basal ganglia from the mass effect. Such patients 
can be challenged with dopamine agonists to monitor their response to treatment and assess future outcome.
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